Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-010785
Filing Date
2024-09-23
Accepted
2024-09-23 13:36:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29074
2 filename2.txt TEXT-EXTRACT 2535
  Complete submission text file 0000000000-24-010785.txt   43627
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
TNF Pharmaceuticals, Inc. (Filed for) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 001-36268
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)